Figure 2.
Nomogram including age, gender, number of combined oral drugs, and history of gastrointestinal disorders for the risk of gastrointestinal side effects in patients using glucagon-like peptide-1 receptor agonists.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.